Country Profile

Rwanda

Rwanda is a growing market for Indian pharmaceuticals — $21.9M in FY 2025–26. Medicines accounts for 88% of shipments, with vaccines contributing $1.39M.

🇷🇼 $21.9M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$21.9M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
88%
Medicines Share
4
Product Categories Supplied
12
Years of Trade Data
Rwanda is a growing market for Indian pharmaceuticals — $21.9M in FY 2025–26. Medicines accounts for 88% of shipments, with vaccines contributing $1.39M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $19.3M (88.4%) Vaccines $1.39M (6.4%) Surgical & Hospital Supplies $1.06M (4.8%) Medicine Ingredients $91K (0.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Rwanda in the RBI overseas direct investment dataset (2011–2026).